Rural health care in Tennessee is at a crossroads, but hope is on the horizon | Opinion
While rural health remains at a crossroads, there are programs that could provide rural Tennesseans access to high-quality health care.
UTHSC In the Media
Rural health care in Tennessee is at a crossroads, but hope is on the horizon | Opinion
While rural health remains at a crossroads, there are programs that could provide rural Tennesseans access to high-quality health care.
Lumosa Therapeutics Announces Positive Results from Lt3001(Intravenous Odatroltide) Phase 2b Clinical Trial in Acute Ischemic Stroke
Lumosa Therapeutics (Lumosa; 6535.TWO) today announced positive results from its Phase 2b clinical trial (LT3001-202) evaluating LT3001 (intravenous Odatroltide) in patients with acute ischemic stroke.
Lumosa Therapeutics Announces Positive Results from Lt3001(Intravenous Odatroltide) Phase 2b Clinical Trial in Acute Ischemic Stroke
Lumosa Therapeutics (Lumosa; 6535.TWO) today announced positive results from its Phase 2b clinical trial (LT3001-202) evaluating LT3001 (intravenous Odatroltide) in patients with acute ischemic stroke.
Lumosa Therapeutics Announces Positive Results from Lt3001(Intravenous Odatroltide) Phase 2b Clinical Trial in Acute Ischemic Stroke
Lumosa Therapeutics (Lumosa; 6535.TWO) today announced positive results from its Phase 2b clinical trial (LT3001-202) evaluating LT3001 (intravenous Odatroltide) in patients with acute ischemic stroke.
COLUMN: It’s time to bring back NCAA Boxing
Full-contact sports are a huge staple of the college institution.
Business Spotlight – Dr. Stephen Snell new Family Medicine Provider at The Jackson Clinic
The Jackson Clinic is excited to welcome Dr. Stephen Snell to its Family Practice department.
Jackson Clinic welcomes new family medicine provider
The Jackson Clinic has added a new medicine provider to their Milan location.